The baculovirus expression system has been utilized for the expression of a wide variety of proteins in insect cells (1, 2) . Unfortunately, yields of the secreted proteins are often much lower than those obtained for nonsecreted proteins (3) . IgG antibodies are one of the many proteins that have been secreted in a functional and active form from the baculovirus-insect cell system (4, 5) . However, a substantial fraction of the immunoglobulin is observed to accumulate intracellularly in the form of incorrectly associated chains and insoluble aggregates (4, 6) . This suggests that post-translational processing in insect cells may be unable to accommodate the high level expression of immunoglobulins (7) . In recent years, it has become evident that the proper folding and post-translational modification of nascent polypeptides in the cell can be assisted by additional cellular factors including folding enzymes and chaperones (8) .
In the absence of sufficient levels of these cellular proteins, the polypeptides may fail to fold correctly or they may associate into aggregates. Improper polypeptide processing and protein aggregation can be especially problematic in baculovirus-infected insect cells since heterologous protein production can be very high during the late stages of the baculovirus infection, and synthesis of host chaperones and folding enzymes will be repressed during the viral infection (2, 3, 9, 10) .
Folding and assembly of IgG antibodies in the endoplasmic reticulum is believed to be assisted by a number of cellular proteins including the endoplasmic reticulum-localized enzyme, protein disulfide isomerase (PDI). 1 PDI levels have been observed to increase with the maturation of B cells (11) and with immunoglobulin synthesis rates (12) . IgG includes multiple intrachain and interchain disulfide bonds, and chemical cross-linking reagents have been shown to generate covalent complexes between PDI and the immunoglobulins in hybridomas (13) . Furthermore, in vitro studies have demonstrated that the presence of PDI can improve the reactivation yield of reduced and denatured antibody Fab fragments (14) . In fact, the coexpression of a heterologous PDI has been observed to enhance intracellular immunoglobulin solubility and IgG secretion from baculovirus-infected insect cells (15) . Expression of PDI has also been observed to increase yields of select heterologous protein produced in other hosts including yeast (16, 17) and Escherichia coli (18, 19) .
PDI is a multifunctional protein that includes several structural and functional domains. The enzyme includes two thioredoxin-like domains, one near the amino terminus and the other near the carboxyl terminus of the protein. Each domain con-tains highly conserved motifs along with the active site sequence, CGHC. This sequence is important in catalyzing thioldisulfide exchange reactions in vitro leading to oxidation, reduction, or isomerization of protein disulfide bonds (20, 21) . Mutations at the first cysteine 2 of the active site in either the amino-or carboxyl-terminal thioredoxin domain will inhibit the capacity of PDI to catalyze thiol-disulfide exchange reactions in vitro (22, 23) , and mutations at both initial cysteines reduce enzymatic activity to negligible levels (23, 24) . PDI also comprises the ␤-subunit of the tetramer prolyl-4-hydroxylase (25) and microsomal triglyceride transfer protein (26) . Synthesis of the ␣-subunits in insect cells in the absence of coexpressed PDI leads to aggregation and insolubility of these subunits (27) . Interestingly, coexpression of a PDI mutant containing serine at the first cysteine of both CGHC active site sequences was still able to form soluble and active prolyl hydroxylase (␣ 2 ␤ 2 ) tetramers and microsomal triglyceride transfer protein in insect cells even though this PDI variant could not facilitate disulfide isomerase reactions in vitro (25) . 3 PDI has also been observed to prevent aggregation of other proteins in vitro in a role comparable to chaperones (28, 29) . Conversely, PDI can facilitate the in vitro aggregation of lysozyme at select substrate and enzyme concentrations in an anti-chaperoning role (30) . The active sites' cysteines are not required for the anti-chaperoning function of PDI (31) since mutation of these cysteines to serines leads to anti-chaperone activity at all PDI concentrations. PDI also includes a distinct peptide binding site near the carboxyl terminus of the protein that will bind peptides and unfolded proteins with a slight propensity for peptides containing cysteine residues (32) (33) (34) .
The relevance of the amino-and carboxyl-terminal thioredoxin domains to PDI's enhancement of immunoglobulin solubility and secretion from baculovirus-infected insect cells is not understood. Although the two active sites can function independently in vitro (22) , the two domains do not possess equivalent catalytic activities or substrate binding affinities (23) . To evaluate the role of the amino-and carboxyl-terminal active site sequences, wild-type human PDI and three mutants were expressed in insect cells. These PDI variants included serine mutations at the first, more reactive, active site cysteine of the amino (PDI-N), carboxyl (PDI-C), or both (PDI-NC) thioredoxin-like domains of PDI (22) . Coexpression of these PDI mutants with immunoglobulin G in baculovirus-infected insect cells produced substantially different effects on the immunoglobulin solubility and secretion. Although the amino-terminal PDI mutant enhanced immunoglobulin solubility and provided IgG secretion levels similar to those of the wild-type enzyme, the carboxyl-terminal variant (PDI-C) and N ϩ C variant (PDI-NC) lowered both immunoglobulin and PDI solubility in an anti-chaperoning role. Hence, the two thioredoxin-like domains, when mutated, act significantly different in vivo in their ability to alter immunoglobulin solubility.
EXPERIMENTAL PROCEDURES
Construction of PDI and PDI Mutant Expression Vectors-The transfer vectors containing the human PDI and PDI mutants were kindly provided by K. Kivirikko (University of Oulu, Finland). The three mutants of PDI were generated by mutagenesis of one or both catalytic sites (22) . Standard recombinant DNA techniques were used for the construction of recombinant baculovirus vectors utilizing the BacPAK Baculovirus Expression System (CLONTECH). The recombinant baculoviruses PDI-WT, PDI-C, PDI-N, and PDI-N/C were each constructed following co-transfection of Sf-9 cells with the appropriate transfer vector and the linearized wild-type baculovirus (Autographa californica nuclear polyhedrosis virus, AcNPV) (CLONTECH). Plaque assays were performed to select recombinant baculovirus by identifying plaques in low melting point agarose overlays.
The construction of the AcBB negative control containing the gene for ␤-galactosidase but without PDI insert has been described previously (35) . The recombinant baculovirus for immunoglobulin G 2a , JPLH, containing genes for both the heavy and light chain subunits of an antibody directed against lipoprotein I of Pseudomonas aeruginosa was kindly provided by Horst Domdey (5) .
Cell Culture-Spodoptera frugiperda (Sf-9) cells were maintained in monolayer and adapted to suspension. Suspension cultures were maintained at 27°C in shaker flasks with 30 ml of ExCell 401 (JRH Biosciences). High Five (BTI-TN5B1-4) (36) (Invitrogen) insect cells adapted to suspension were maintained at 27°C in shaker flasks with 30 ml of ExCell 405 (JRH Biosciences). Cells were subcultured onto monolayers for infection at a density of 1 ϫ 10 6 cells/ml. SDS-PAGE/Immunoblot-High Five (BTI-TN5B1-4) cells (2.5 ϫ 10 5 cells/well) infected with recombinant baculovirus in 24-well plates were collected and disrupted. Methods for the disruption of the cells have been described previously (6) . Samples were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing and denaturing conditions on a 15% gel followed by Coomassie Blue staining or by transferring onto a nitrocellulose membrane (37) . Nitrocellulose sheets were either incubated with 1:2000 dilution of polyclonal rabbit anti-PDI (Stressgen) antibody followed by incubation with horseradish peroxidase-conjugated goat anti-rabbit IgG antibody for detecting PDI or directly incubated with 1:10,000 dilution of horseradish peroxidase-conjugated rabbit anti-mouse IgG antibody (Pierce) for detecting recombinant IgG. Purified bovine PDI was used as the immunogen for the polyclonal anti-PDI antibody, which is known to cross-react with human, monkey, rat, mouse, and hamster PDI (Stressgen). Blots were developed with the enhanced chemiluminescence system (Kirkegaard & Perry Laboratories) (35) .
Short Term Metabolic Labeling-Insect cells were plated and infected in a 24-well plate at the density of 2.5 ϫ 10 5 cells/well. At 44 h post-infection, cells were incubated with 0.5 ml/well of methionine-free Excell 401 media (JRH Biosciences) for 1 h followed by labeling with 50 Ci/well of Trans-labeled [
35 S]methionine and -cysteine (ICN Biomedicals) in methionine-free media. At the end of the labeling period, cells were harvested and lysed in buffer (1% Triton X-100, 150 mM NaCl, 50 mM Tris-HCl, 10 mM EDTA, 20 mM iodoacetamide, pH 7.5, with freshly added phenylmethylsulfonyl fluoride (1 mM)) on ice for 20 min. After clarification at 16,000 ϫ g at 4°C for 12 min to separate the soluble proteins from insoluble protein and aggregates (38) , lysates were immunoprecipitated with polyclonal rabbit anti-murine IgG (heavy and light chains) (Pierce) and Protein A-Sepharose (Pharmacia Biotech Inc.) overnight. Beads were washed twice with cold phosphate-buffered saline, pH 7.4. Immunoprecipitates were analyzed with 15% SDS-PAGE under reducing and denaturing conditions. The labeling medium was collected, immunoprecipitated, and analyzed with reducing and denaturing SDS-PAGE for soluble IgG. The radioactive bands were visualized by soaking the gels in Amplifier (Amersham Life Sciences, Inc.) fluorographic reagent for 20 min. The gels were then dried and exposed to Kodak XAR-5 autoradiographic film.
Long Term Metabolic Labeling-High Five cells infected in 24-well plates (2.5 ϫ 10 5 cells/well) were starved with methionine-deficient Excell 401 (JRH Bioscience) at 44 hpi for 1 h. Cells were then incubated with 50 Ci/ml Trans-labeled 35 S for 4 h. At the end of the labeling period, cells were harvested, lysed, immunoprecipitated with polyclonal rabbit anti-murine IgG (Pierce) and Protein A-Sepharose (Pharmacia), and analyzed by 15% SDS-PAGE under reducing and denaturing conditions followed by autoradiography as described.
Extended Metabolic Labeling-High Five cells infected in 24-well plates (2.5 ϫ 10 5 cells/well) were starved with methionine-deficient Excell 401 (JRH Bioscience) at 44 h post-infection for 1 h. Cells were then incubated with 50 Ci/ml Trans-labeled 35 S for 6 -24 h. At the end of the labeling period, cells were harvested, lysed, immunoprecipitated with polyclonal rabbit anti-PDI IgG (Stressgen) or polyclonal rabbit anti-murine IgG antibody (Pierce) and Protein A-Sepharose (Pharmacia). The samples were then analyzed by 15% SDS-PAGE followed by autoradiography as described.
Scanning Densitometry-The films were scanned with Apple One Scanner (Apple Computer, Inc.). The scanned films were quantified by means of the image analysis and processing software NIH Image (ver-sion 1.49). This software permits the measurement of the density of a specified area.
RESULTS

Expression of PDI Variants and Immunoglobulin in Baculovirus-infected Insect Cells-Baculovirus vectors containing
wild-type human PDI and several mutant PDIs were created from baculovirus transfer plasmids kindly provided by Kivirikko and coworkers (25) . The PDI constructs utilized in this study are shown in Fig. 1 along with the particular modifications within the active site sequence. Each of the PDI variants includes a mutation of the first active site cysteine to serine in either the amino-and/or carboxyl-terminal thioredoxin domain. To verify expression of each PDI, Trichoplusia ni (BTI-TN5B1-4, High Five) (36) insect cells were infected with the specific recombinant baculovirus construct of interest for 3 days followed by cell lysis, protein separation on a 15% SDS-PAGE, and staining with Coomassie Blue stain (Fig. 2) . A distinct protein band at approximately 58 kDa was observed for the wild-type and mutant PDIs that was not observed for an infection with the virus, JPLH, coding for murine immunoglobulin G (IgG). Viral stocks of each of the PDI variants were then generated and titered to provide sufficient virus for coinfection studies.
To provide simultaneous expression of PDI and the immunoglobulins, duplicate cultures of T. ni insect cells were coinfected with a different PDI virus in concert with the recombinant baculovirus, JPLH. High Five infections were performed at a multiplicity of infection of 5 for each virus to ensure simultaneous infection of the cells by the two different viruses (39) . After several days' infection, the cells were harvested, lysed under reducing and denaturing conditions, and the proteins analyzed by SDS-PAGE followed by immunoblotting with rabbit anti-PDI antibody or anti-mouse IgG antibody (heavy and light chain-specific). Shown in Fig. 3 are the Western blots of the cell lysates for the coinfections with each of the PDI virus variants. A distinct protein band was detected for each infection using a PDI virus (Fig. 3a) to indicate that the PDI variants were expressed and recognized by the rabbit polyclonal antibody. The antibody did not detect any PDI in the uninfected cells or cells infected with the control baculovirus (AcBB) to indicate that there was no cross-reaction with any native insect PDI. Also, an examination of PDI levels in the Coomassie gels ( Fig. 2 and data not shown) showed that the level of heterologous PDI was substantially higher than that of most native proteins, which is expected due to the strength of the baculovirus promoter and the shut down of host protein synthesis following viral infection. Expression of significant levels of immunoglobulin heavy chain was also detected in Western blots using the anti-IgG antibody for all the infections (Fig. 3b) . The light chain was also observed although the levels detected were lower since the polyclonal antibody is not as sensitive to light chain (40) . There were some differences in the total immunoglobulin and PDI levels detected due to the relative difficulty in obtaining exact viral titer measurements for the equivalent coinfections. However, it is evident from the Western blot studies in Fig. 3 that synthesis of immunoglobulins and PDI was achieved in all four coinfections. FIG. 1 . PDI mutant proteins. The active sites of PDI are represented as cylinders containing the highly conserved amino acid sequence CGHC. The PDI variants are shown with the point mutation of the first cysteine to serine (-CGHC-to -SGHC-) at either the amino-or carboxyl-terminal thioredoxin-like active site or both active sites (25) . PDI WT represents the wild-type PDI protein with both catalytic sites intact. The PDI-C variant has the first cysteine at the carboxyl-terminal thioredoxin-like active mutated to serine, and the PDI-N variant has the first cysteine at the amino-terminal thioredoxin-like active mutated to serine. The PDI-NC variant is a double mutant with the first cysteines at both the amino-and carboxyl-terminal sites replaced with serines. Radioactive Labeling and Soluble Immunoglobulin Production in the Presence of PDI Variants-After 2 days of baculovirus infection, a sufficient amount of heterologous PDI will be produced to evaluate its effect on immunoglobulin solubility and secretion (7) . Consequently, the effect of coexpressing human wild-type PDI or the PDI mutants on immunoglobulin solubility and secretion was evaluated in radioactive labeling studies. T. ni cells were coinfected with JPLH and baculoviruses coding for PDI, PDI-C, PDI-N, or PDI-NC. After 44 h infection, the cells were labeled in [ 35 S]methionine-and [ 35 S]cysteine-supplemented medium for short (30 min) and long (4 h) periods. Following labeling, the cells were lysed in buffer, and the lysates were clarified by centrifugation, which is known to separate soluble proteins from insoluble proteins and aggregates (38) . The soluble intracellular immunoglobulin proteins were then immunoprecipitated from the clarified cell lysate and analyzed by SDS-PAGE and x-ray fluorography. For both short (Fig. 4) and long (Fig. 5, a and b) labeling periods, significant levels of soluble protein were immunoprecipitated from the High Five cells coinfected with JPLH and wild-type human PDI or the PDI variant, PDI-N. In contrast, the soluble immunoglobulin levels were significantly lower and nearly undetectable for the coinfections with the PDI-C and PDI-NC mutants for both labeling periods. Some intermediate molecular weight protein bands were also observed in the wild-type and PDI-N lanes of Fig. 5a ; these proteins have been shown to be composed of degraded immunoglobulin heavy chains (6) . Especially interesting was the observation that the levels of soluble immunoglobulin detected in the PDI-C and PDI-NC coexpression experiments were even lower than the levels of the soluble immunoglobulin detected from cells coinfected with the negative control virus, AcBB, which does not carry any PDI genes (Fig. 5b) .
The levels of soluble heavy chain detected in the two 4-h labeling experiments were quantified using densitometry and tabulated (Fig. 5c ). This analysis showed that the soluble immunoglobulin levels were more than 70% lower for coinfections with PDI-C or PDI-NC. Parallel samples of unclarified crude lysate were solubilized with SDS for one of these experiments and quantified by densitometry to determine the total heavy chain levels (Fig. 6, a and b) . In contrast to the soluble immunoglobulin levels, the total heavy chain levels synthesized did not vary by more than 20% to indicate that the difference in solubility is due to the nature of the PDI virus and not the immunoglobulin expression level.
To compare the effect of the PDI variants on IgG secretion, samples of the medium were collected for one of the 4-h labeling experiments, and the IgG was immunoprecipitated (Fig. 7) . Immunoglobulin secretion was undetectable in the cells infected with JPLH and PDI-C or PDI-NC, although significantly higher levels were observed from cells infected with JPLH and wild-type PDI or PDI-N. Separate samples run under nonreducing conditions showed that the immunoglobulins were secreted as fully assembled IgG molecules (data not shown). Thus, both the intracellular and secreted soluble immunoglobulin levels were higher from the cells coexpressing wild-type PDI and PDI-N relative to the levels from PDI-C and PDI-NC.
Immunoprecipitation of PDI-To determine if the thioredoxin mutations altered the solubility of PDI, insect cells were infected with wild-type PDI or PDI-NC for 44 h followed by radioactive labeling for an extended period, lysis, clarification, and immunoprecipitation with polyclonal rabbit anti-PDI antibody developed against a purified bovine liver PDI (Stressgen). The polyclonal antibody exhibits cross-reactivity with human, monkey, rat, mouse, and hamster PDI (Stressgen). Soluble PDI was immunoprecipitated from the infection with wild-type PDI (Fig. 8a) , whereas no soluble PDI was immunoprecipitated from the cells infected with PDI-NC. To determine which mutation led to the loss in PDI solubility, the cells were infected with either PDI-N or PDI-C followed by radiolabeling and immunoprecipitation (Fig. 8b) . Soluble levels of PDI-N were immunoprecipitated with anti-PDI antibody, whereas negligible levels of protein were immunoprecipitated from cells infected with PDI-C. Apparently, the carboxyl-terminal mutation provided for a PDI protein which is much less soluble in the insect cells even in the absence of coexpressed immunoglobulins.
The effects of the mutation at the carboxyl-terminal thioredoxin domain on both immunoglobulin and PDI solubility can also be seen in experiments in which the enzyme is coexpressed in concert with the immunoglobulin proteins. Cells were coinfected with JPLH and PDI-N or PDI-C followed by 24-h radiolabeling and immunoprecipitation of soluble proteins with a polyclonal anti-IgG antibody (Fig. 8c) . As has been observed previously for experiments conducted at shorter labeling periods, soluble heavy chains were immunoprecipitated from cells infected with JPLH and PDI-N. In addition, soluble PDI protein coprecipitated from cells infected with JPLH and PDI-N as a result of the 24-h labeling of cellular proteins. In contrast, no soluble immunoglobulin or PDI protein immunoprecipitated from the cells infected with JPLH and PDI-C. Similar results were obtained when the soluble proteins were immunoprecipitated with anti-PDI antibody (data not shown). Evidently, the presence of the immunoglobulin was not essential to the decline in PDI solubility for cells infected with PDI-C; however, the presence of the PDI appears to render both the immunoglobulins and PDI insoluble when the two proteins are coexpressed.
DISCUSSION
In a previous study, an increase in immunoglobulin solubility and secretion was observed from insect cells coexpressing PDI (15) . The current studies demonstrate that PDI mutants containing a serine mutation at the first cysteine of the aminoterminal active site (PDI-N) were capable of increasing soluble immunoglobulin levels above those achieved with a negative control, whereas mutations at the carboxyl-terminal active site (PDI-C and PDI-NC) actually lowered soluble IgG levels in vivo. The levels of soluble and secreted immunoglobulin ob- tained with PDI-N were comparable to those achieved with the wild-type PDI. This may be due to the efficiency of the baculovirus polyhedrin promoter in expressing an excess of PDI enzyme so that numerous catalytic sites are available in the insect cells for facilitating immunoglobulin solubility. The PDI function that provides for the rescue of immunoglobulins from insolubility could be linked to the oxidation, reduction, or isomerization activity at the CGHC active sites of PDI, although the chaperoning activity of PDI may be involved in enhancing immunoglobulin solubility as well (20, 21) . However, the role of PDI in this study must be different from its function as a subunit in the two multimeric proteins, prolyl-4-hydroxylase and microsomal triglyceride transfer protein. Unlike the current studies, the PDI-NC mutant rescued solubility and function for both proteins, which include individual PDI subunits as part of the final protein structure (25) . 3 PDI contains a separate peptide binding region near the extreme end of the carboxyl terminus, and recent studies with other PDI mutants have indicated that this binding domain may be especially relevant to solubilizing the prolyl-4-hydroxylase tetramers (41) . Interestingly, one of these studies also observed that the secretion of an apoB protein fragment containing six disulfides was dramatically reduced in the presence of coexpressed PDI-NC. 3 Therefore, the PDI-NC mutant may lower the secretion of other proteins similar to its effect on IgG solubility and secretion.
An in vitro study by Vuori et al. (22) , using the same serine to cysteine PDI mutants, found that the amino-and carboxylterminal thioredoxin pair could each contribute about 50% to the enzyme's isomerase activity during RNase refolding. Recent in vitro studies with PDI have shown, however, that the amino-and carboxyl-terminal domains are functionally and structurally distinct (23) . Mutants in which both active site cysteines were eliminated at either the amino-or carboxylterminal thioredoxin domains were shown to include distinctly different catalytic activities (k cat ) and binding constants (K m ) for the oxidative folding of reduced RNase A. The carboxylterminal mutant included a k cat with near wild-type catalytic activity but a K m value that was nearly five times greater than the wild type. The amino-terminal mutant included wild-type K m values and k cat activity equal to 1 ⁄3 of the wild-type (23).
Subsequent mutational studies indicated that the principal contributor to the increased K m and lowered binding affinity of the carboxyl-terminal mutant was the first cysteine of the active site (42) . Binding or release of the substrate can be the rate-limiting step in catalysis, and the carboxyl-terminal mutants of the current study may have a lowered binding affinity for the substrate that could minimize their capacity to rescue immunoglobulins in vivo.
However, a reduction in substrate binding alone does not explain why the soluble immunoglobulin levels for PDI-C and PDI-NC were actually lower than coinfections with the negative control baculovirus, AcBB, in the current studies. In addition, negligible levels of soluble PDI were immunoprecipitated using anti-PDI antibody for cells expressing PDI-C and PDI-NC. The PDI-C and PDI-NC mutants appear to facilitate immunoglobulin and PDI insolubility in a role comparable to anti-chaperones. The capacity for PDI to increase aggregation of lysozyme has been observed in vitro for PDI mutants at all concentrations as well as for the wild-type PDI over a limited concentration range (30, 31) . The PDI mutants were observed to form non-covalent associations with lysozyme and a significant fraction of the mutant PDI was insoluble along with lysozyme. The current studies indicate that the catalyst's antichaperoning activity exists in vivo as well, at least for PDI variants containing cysteine to serine mutations in the active site. Transient or sustained protein aggregation has been observed in vivo under other conditions such as overexpression of heterologous proteins (43) , alteration of cellular redox environment (44, 45) , or ATP depletion (46) , and a role for PDI in both aggregation and disaggregation has been suggested (30, 44) . In contrast, the PDI-N mutant did not facilitate significant immunoglobulin aggregation in the current studies and actually increased soluble and secreted IgG as observed for the wildtype. Consequently, the two domains of PDI appear to have differing anti-chaperoning capabilities in vivo.
The PDI protein has yet to be crystallized, but sequence and intron-exon analysis have indicated that the domain grouping for the structure of the PDI protein is as follows (20) : a-e-bbЈ-aЈ-c. The a and aЈ domains, containing the CXXC active site sequences, are similar to each other, thioredoxin, and the bacterial protein DsbA. Other regions such as the peptide binding domain in region c are likely to be relevant to activities such as assembly of prolyl-4-hydroxylase, triglyceride transferase, and calcium binding (20) . To characterize the function and structure of the two thioredoxin domains of PDI, separate versions of the a and aЈ domains were cloned and expressed independently in E. coli (47) . Although the two expressed domains were observed to have approximately equivalent catalytic activities, the aЈ (carboxyl-terminal) domain was much less stable and tended to unfold and aggregate. Furthermore, a cysteine to serine mutation of the first cysteine of the aЈ active site, which is equivalent to the PDI-C mutation of the current study, rendered the aЈ domain completely unfolded and insoluble (48) . This domain is also likely to be unstable in the complete PDI protein (47) although the altered protein can be solubilized, at least in vitro (49) . A decline in PDI solubility may be expected in an in vivo environment containing very high levels of the altered PDI along with other unfolded, partially folded, and unassembled polypeptides. In contrast, mutants of the a fragment containing a cysteine to serine mutation were soluble and retained the folded structure, suggesting that a mutation in the amino-terminal thioredoxin domain of PDI does not appear to induce the same loss of structural stability (48) . These in vitro studies indicate that the two thioredoxin domains of PDI include significant, if subtle, structural and functional differences. These differences may have implications in the ability of the thioredoxin domains, when mutated, to increase or decrease immunoglobulin solubility in vivo.
It is curious to consider why the native PDI molecule would retain two thioredoxin domains if the second one is much less stable. This would suggest that the carboxyl-terminal thioredoxin domain is advantageous for particular PDI functions. The lowered structural stability of the aЈ domain may provide some benefits in certain PDI applications. In fact, it has been observed that PDI's high reactivity and non-covalent interactions can enhance the stability of unfolded proteins (50) . Enhancing stability of unfolded proteins may be advantageous in preventing accumulation of kinetic traps during productive folding (50); however, it could also lead to protein aggregation for mutant PDIs or wild-type PDI in an unfavorable folding environment. Consequently, the presence of PDI may provide significant benefits for many cell functions, whereas a disruption to PDI or the cell environment could lead to undesirable anti-chaperoning activities under other conditions.
